Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson
Eli Lilly signs deal for MeiraGTx's gene therapy for severe eye disease